These results suggest that the improvement of mSMG and berberine on hepatic IR and glycogen synthesis in T2DM involves the inhibition of TNF-α/JNK1/IRS-2 pathway, and berberine may be a representative compound of mSMG. This evidence concerns the gene MAPK8 and type 2 diabetes mellitus.